Profusa, Inc.

Profusa, Inc. (Nasdaq: NVAC) is a medical technology company focused on implantable biosensing platforms designed to enable continuous, real-time monitoring of tissue biochemistry, including tissue oxygen levels. Profusa reached the public markets through a special purpose acquisition company structure, operating within the healthcare and medical devices sector. The company filed an 8-K with the SEC on March 14, 2024, reflecting its active reporting obligations as a publicly traded post-combination entity. For full filing histories, sponsor details, deal timelines, and advanced analytics on NVAC and hundreds of other SPAC vehicles, sign up for complete access at SpacDesk.